Literature DB >> 23129415

The role of the manipulation of the gut microbiota in obesity.

Matthieu Million1, Didier Raoult.   

Abstract

The manipulation of the gut microbiota by diet, antibiotics, or probiotics could promote, prevent, or reverse the development of specific diseases, including obesity. A link has been proposed between obesity and the growth promoters (probiotics and antibiotics) that have been used in animals for more than 40 years to induce weight gain. Several species of the Lactobacillus genus that are frequently used as probiotics for human consumption merit particular attention because they are increased in the gut microbiota under high-fat diets, are more abundant in obese humans, and are selected by growth-promoter antibiotics; moreover, the administration of these bacteria in experimental models is linked to the development of obesity. However, other species or strains of the same genus are associated with an antiobesity effect. Newborns and infants are a particularly susceptible population in which the administration of antibiotics or probiotics could be related to the development of obesity in adulthood.

Entities:  

Year:  2013        PMID: 23129415     DOI: 10.1007/s11908-012-0301-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

Review 1.  A special fondness for lactobacilli.

Authors:  Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

Review 2.  Probiotics, their health benefits and applications for developing healthier foods: a review.

Authors:  Ravinder Nagpal; Ashwani Kumar; Manoj Kumar; Pradip V Behare; Shalini Jain; Hariom Yadav
Journal:  FEMS Microbiol Lett       Date:  2012-05-28       Impact factor: 2.742

3.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.

Authors:  Y Kadooka; M Sato; K Imaizumi; A Ogawa; K Ikuyama; Y Akai; M Okano; M Kagoshima; T Tsuchida
Journal:  Eur J Clin Nutr       Date:  2010-03-10       Impact factor: 4.016

4.  Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.

Authors:  A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz
Journal:  Br J Nutr       Date:  2010-03-08       Impact factor: 3.718

5.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

6.  Minocycline in the antibiotic regimen of cystic fibrosis patients: weight gain and clinical improvement.

Authors:  P R Patterson
Journal:  Clin Pediatr (Phila)       Date:  1977-01       Impact factor: 1.168

7.  Antibiotics in early life alter the murine colonic microbiome and adiposity.

Authors:  Ilseung Cho; Shingo Yamanishi; Laura Cox; Barbara A Methé; Jiri Zavadil; Kelvin Li; Zhan Gao; Douglas Mahana; Kartik Raju; Isabel Teitler; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

8.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.

Authors:  Peter J Turnbaugh; Fredrik Bäckhed; Lucinda Fulton; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

9.  Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.

Authors:  Yan Y Lam; Connie W Y Ha; Craig R Campbell; Andrew J Mitchell; Anuwat Dinudom; Jan Oscarsson; David I Cook; Nicholas H Hunt; Ian D Caterson; Andrew J Holmes; Len H Storlien
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  13 in total

Review 1.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 3.  The Gut Microbiome and Obesity.

Authors:  George Kunnackal John; Gerard E Mullin
Journal:  Curr Oncol Rep       Date:  2016-07       Impact factor: 5.075

4.  Oral Lactobacillus Counts Predict Weight Gain Susceptibility: A 6-Year Follow-Up Study.

Authors:  Johanne Aviaja Rosing; Karen Christina Walker; Benjamin A H Jensen; Berit L Heitmann
Journal:  Obes Facts       Date:  2017-10-12       Impact factor: 3.942

5.  Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age.

Authors:  Frida Karlsson Videhult; Inger Öhlund; Hans Stenlund; Olle Hernell; Christina E West
Journal:  Eur J Nutr       Date:  2014-05-17       Impact factor: 5.614

6.  Obesity in school-aged children and its correlation with gut E.coli and Bifidobacteria: a case-control study.

Authors:  Xiaolin Gao; Ruizhen Jia; Liang Xie; Linghan Kuang; Ling Feng; Chaomin Wan
Journal:  BMC Pediatr       Date:  2015-05-30       Impact factor: 2.125

7.  Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment.

Authors:  M Million; F Thuny; E Angelakis; J-P Casalta; R Giorgi; G Habib; D Raoult
Journal:  Nutr Diabetes       Date:  2013-09-09       Impact factor: 5.097

8.  Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats.

Authors:  Bernardo A Petriz; Alinne P Castro; Jeeser A Almeida; Clarissa Pc Gomes; Gabriel R Fernandes; Ricardo H Kruger; Rinaldo W Pereira; Octavio L Franco
Journal:  BMC Genomics       Date:  2014-06-21       Impact factor: 3.969

9.  Influence of Panax ginseng on obesity and gut microbiota in obese middle-aged Korean women.

Authors:  Mi-Young Song; Bong-Soo Kim; Hojun Kim
Journal:  J Ginseng Res       Date:  2014-01-09       Impact factor: 6.060

10.  Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli.

Authors:  M Million; E Angelakis; M Maraninchi; M Henry; R Giorgi; R Valero; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2013-03-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.